The master regulators of delayed-type drug hypersensitivity reactions

Current Opinion in Allergy and Clinical Immunology · Published 2026-05-20 · DOI 10.1097/aci.0000000000001170

Authors (3)

Lele Sun, Hong Liu, Furen Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sun, L., Liu, H., Zhang, F. (2026). The master regulators of delayed-type drug hypersensitivity reactions. Current Opinion in Allergy and Clinical Immunology. https://doi.org/10.1097/aci.0000000000001170

Related articles

• Epinephrine nasal spray for the treatment of anaphylaxis: perspectives in pediatrics · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal
• New aspects of chronic beryllium disease · Current Opinion in Allergy and Clinical Immunology · 2026 · Same journal
• Allergen immunotherapy: effective on lung function? · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal
• Skin intervention for food allergy prevention: recent advances and clinical implications · Current Opinion in Allergy and Clinical Immunology · 2026 · Same journal
• The interplay of chronic rhinitis and sleep-disordered breathing · Current Opinion in Allergy and Clinical Immunology · 2026 · Same journal
• Unraveling the immune–microbial axis in chronic ocular surface disease · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal
• CTLA4-related primary immune dysregulatory disorders · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal
• Immediate hypersensitivity to herbal medicine: from diagnosis to policies · Current Opinion in Allergy and Clinical Immunology · 2026 · Same journal
• DOCK8 deficiency · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal
• Skin pain in pediatric atopic dermatitis: mechanisms and management · Current Opinion in Allergy and Clinical Immunology · 2025 · Same journal